With support from WHO, the East Africa Community countries are working jointly to share the costs of regulatory work and expedite the approval of life-saving medical products. Recently, they jointly assessed and registered two critical bio therapeutic products for cancer. MSH/SIAPS is supporting the EAC medicines regulatory harmonisation initiative in strengthening PV in EAC partners’ states and will ensure uptake of the PAVIA blueprint in these countries.